✦ LIBER ✦

A comparison of the pharmacokinetics of meropenem after intravenous administration by injection over 2, 3 and 5 minutes

✍ Scribed by H. K. Jones; H. C. Kelly; M. Hutchison; R. A. Yates; F. Ross; C. Lomax; S. Freestone; D. Webb

Publisher: Springer-Verlag
Year: 1997
Tongue: English
Weight: 771 KB
Volume: 22
Category: Article
ISSN: 0378-7966
DOI: 10.1007/bf03189806

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of the pharmacokinetics and e

Comparison of the pharmacokinetics and efficacy of irinotecan after administration by the intravenous versus intraperitoneal route in mice

✍ Sylvie Guichard; Etienne Chatelut; Isabelle Lochon; Roland Bugat; Mondher Mahjou 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 242 KB

Pharmacokinetics and pharmacodynamics of

Pharmacokinetics and pharmacodynamics of a single dose of recombinant human growth hormone after subcutaneous administration by jet-injection: comparison with conventional needle-injection

✍ A. Verhagen; J. T. Ebels; J. H. G. Jonkman; A. A. Dogterom 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 331 KB

The pharmacokinetics and pharmacodynamics of recombinant human growth hormone (rhGH) were studied after a single subcutaneous dose given by jet-injection, and have been compared with the results obtained after conventional needle-injection. Twelve healthy male volunteers completed an open label, ra

Plasma pharmacokinetics and bioavailabil

Plasma pharmacokinetics and bioavailability of 1-(2-chloroethyl)-3-sarcosinamide-1-nitrosourea after intravenous and oral administration to mice and dogs

✍ Jeffrey G. Supko; Rocio Garcia-Carbonero; Thomas A. Puchalski; Louis Malspeis 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 126 KB

Pharmacokinetic study of3H-labelled PAF-

Pharmacokinetic study of3H-labelled PAF-acether II. Comparison with3H-labelled lyso-PAF-acether after intravenous administration in the rabbit and protein binding

✍ C. Lartigue-Mattei; D. Godeneche; J. L. Chabard; J. Petit; J. A. Berger 📂 Article 📅 1984 🏛 SP Birkhäuser Verlag Basel 🌐 English ⚖ 284 KB

THE PHARMACOKINETICS OF 1954U89, 1, 3-DI

THE PHARMACOKINETICS OF 1954U89, 1, 3-DIAMINO-7-(1-ETHYLPROPYL)-8-METHYL-7H-PYRROLO-(3, 2-f )QUINAZOLINE, IN DOGS AND RATS AFTER INTRAVENOUS AND ORAL ADMINISTRATION

✍ S. D. STUDENBERG; J. L. WOOLLEY; D. V. DEANGELIS; W. A. WARGIN 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

1954U89, 1, 3-diamino-7-(1-ethylpropyl)-8-methyl-7H-pyrrolo-(3, 2-f )quinazoline, is a potent, lipid-soluble inhibitor of dihydrofolate reductase. The pharmacokinetics and bioavailability of 1954U89 were examined in male beagle dogs and male CD rats. Dogs received single intravenous (2´5 mg kg 71 )

Pharmacokinetic changes of M1, M2, M3 an

Pharmacokinetic changes of M1, M2, M3 and M4 after intravenous administration of a new anthracycline, DA-125, to rats pretreated with phenobarbital, 3-methylcholanthrene, chloramphenicol, or SKF-525A

✍ Yun J. Choi; Hee J. Lee; Jong W. Kwon; Won B. Kim; Junnick Yang; Myung G. Lee 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB 👁 2 views

The pharmacokinetics of M1 -M4, the metabolites of a new anthracycline antineoplastic agent, DA-125, were compared after intravenous (IV) administration of DA-125, 15 mg kg -1 , to rats pretreated with enzyme inducers, such as phenobarbital (PBT, n =14) and 3-methylcholanthrene (MCT, n= 15), or enzy